Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3038

Actual shortage: 231 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2784 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2018-07-04 2018-12-28 54297
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2020-12-18 2021-01-19 130410
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2021-05-07 2021-06-14 138966
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2021-10-01 2021-10-01 146511
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2022-12-16 2023-03-02 178790
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2023-04-21 2023-06-23 189991
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2023-08-12 2023-11-17 201699
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2024-02-09 2024-03-29 219165
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2018-02-21 2018-08-09 40354
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2020-01-15 2020-02-01 103370
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2020-12-04 2021-06-14 129608
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2021-06-04 2021-06-14 140423
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2021-09-24 2021-10-05 146157
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2022-01-14 2022-02-07 152770
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2022-08-11 2022-10-20 166445
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2022-08-12 2022-10-20 166601
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-01-06 2023-03-02 180113
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-04-27 2023-06-23 190859
APO-NAPROXEN 500MG TABLET Resolved 2017-10-03 2018-03-01 24274
APO-NAPROXEN 250MG TABLET Resolved 2018-02-01 2018-04-05 37971

Showing 1201 to 1220 of 3038

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RISEDRONATE 35MG TABLET Discontinued 2018-09-08 2018-09-15 60747
APO-RISEDRONATE 35MG TABLET Discontinued 2018-10-19 2018-10-19 64965
APO-RILUZOLE 50MG TABLET To be discontinued 2018-09-08 2018-09-08 60744
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-QUININE 200MG CAPSULE Discontinued 2018-09-08 2021-05-10 60711
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-QUETIAPINE 300MG TABLET Discontinued 2018-09-08 2018-12-28 60708
APO-QUETIAPINE 25MG TABLET Discontinued 2020-07-10 2020-07-10 119950

Showing 81 to 100 of 356